• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凸显南亚心力衰竭流行情况。

Highlighting the South Asian Heart Failure Epidemic.

作者信息

Srinivasan Nikhilesh, Gullapalli Nagesh, Shah Kevin S

机构信息

Department of Internal Medicine, Swedish Medical Center Denver, CO, US.

Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah Salt Lake City, UT, US.

出版信息

Card Fail Rev. 2024 Jul 16;10:e07. doi: 10.15420/cfr.2023.21. eCollection 2024.

DOI:10.15420/cfr.2023.21
PMID:39144581
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11322948/
Abstract

Heart failure (HF) remains a progressive syndrome with high morbidity and mortality, and accounts for many hospitalisations globally with a downstream impact of increasing healthcare costs. South Asian individuals account for most of the global burden of non-communicable diseases. In this systematic review, a literature search was performed for all studies focusing on South Asians and HF using PubMed as the primary research tool and citations were included from relevant MEDLINE-indexed journals. Upon identification of relevant studies, pertinent data points were extracted systematically from each eligible study. South Asians have an earlier age of onset of many non-communicable diseases compared to other ethnic groups worldwide, including cardiovascular disease (CVD). Given the large number of South Asians impacted by CVD and both traditional and non-traditional risk factors for CVD, HF has the potential to become an epidemic among South Asians across the world. Individuals of South Asian origin are at elevated risk for CVD compared to many other populations and should be followed closely for the potential development of HF. This review describes what is unique to South Asian individuals at risk for and with established HF, as well as management and prognostic considerations. Future directions and potential policy changes are highlighted that can reduce the HF burden among South Asians globally.

摘要

心力衰竭(HF)仍然是一种具有高发病率和死亡率的进行性综合征,在全球范围内导致许多人住院,进而增加了医疗成本。南亚人群占全球非传染性疾病负担的大部分。在这项系统评价中,以PubMed作为主要研究工具,对所有关注南亚人和心力衰竭的研究进行了文献检索,并纳入了相关MEDLINE索引期刊的参考文献。在确定相关研究后,从每项符合条件的研究中系统地提取相关数据点。与世界其他种族群体相比,南亚人许多非传染性疾病的发病年龄更早,包括心血管疾病(CVD)。鉴于大量南亚人受到CVD以及CVD的传统和非传统危险因素的影响,HF有可能在全球南亚人群中成为一种流行病。与许多其他人群相比,南亚裔个体患CVD的风险更高,应密切关注其是否有患HF的潜在可能。本综述描述了有患HF风险和已确诊HF的南亚个体的独特之处,以及管理和预后方面的考虑因素。强调了未来的方向和潜在的政策变化,这些变化可以减轻全球南亚人群的HF负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfac/11322948/551c3133ddc1/cfr-10-e07-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfac/11322948/551c3133ddc1/cfr-10-e07-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfac/11322948/551c3133ddc1/cfr-10-e07-g001.jpg

相似文献

1
Highlighting the South Asian Heart Failure Epidemic.凸显南亚心力衰竭流行情况。
Card Fail Rev. 2024 Jul 16;10:e07. doi: 10.15420/cfr.2023.21. eCollection 2024.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
The Upcoming Epidemic of Heart Failure in South Asia.南亚即将到来的心力衰竭流行。
Circ Heart Fail. 2020 Oct;13(10):e007218. doi: 10.1161/CIRCHEARTFAILURE.120.007218. Epub 2020 Sep 23.
4
Cardiovascular disease risk and pathophysiology in South Asians: can longitudinal multi-omics shed light?南亚人的心血管疾病风险与病理生理学:纵向多组学能否提供线索?
Wellcome Open Res. 2021 May 20;5:255. doi: 10.12688/wellcomeopenres.16336.2. eCollection 2020.
5
Cardiovascular health amongst South Asian populations in British Columbia: A situational and comparative analysis of preventative strategies.不列颠哥伦比亚省南亚人群的心血管健康:预防策略的现状与比较分析
Curr Probl Cardiol. 2024 Jun;49(6):102570. doi: 10.1016/j.cpcardiol.2024.102570. Epub 2024 Apr 9.
6
Heart failure among South Asians: a narrative review of risk, nature, outcomes and management.南亚人心力衰竭:风险、性质、结局和管理的叙述性综述。
Heart Fail Rev. 2013 Mar;18(2):197-206. doi: 10.1007/s10741-012-9319-x.
7
Childhood cardiovascular risk factors in South Asians: A cause of concern for adult cardiovascular disease epidemic.南亚儿童心血管危险因素:成人心血管疾病流行的一个担忧原因。
Ann Pediatr Cardiol. 2011 Jul;4(2):166-71. doi: 10.4103/0974-2069.84663.
8
The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.南亚人代谢综合征:流行病学、决定因素与预防。
Metab Syndr Relat Disord. 2009 Dec;7(6):497-514. doi: 10.1089/met.2009.0024.
9
Community-based care for the specialized management of heart failure: an evidence-based analysis.基于社区的心力衰竭专科管理:一项循证分析
Ont Health Technol Assess Ser. 2009;9(17):1-42. Epub 2009 Nov 1.
10
Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data.南亚人心血管疾病的预测与观察:将芬兰心血管疾病风险评估(FINRISK)模型、弗明汉模型和系统性冠状动脉风险评估(SCORE)模型应用于纽卡斯尔心脏项目数据
J Public Health (Oxf). 2005 Mar;27(1):93-100. doi: 10.1093/pubmed/fdh202.

引用本文的文献

1
Beyond conventional therapy: NOX4 as a promising target in cardiomyopathy.超越传统疗法:NOX4作为心肌病的一个有前景的靶点。
Mol Biol Rep. 2025 Jul 11;52(1):704. doi: 10.1007/s11033-025-10818-3.
2
Emerging risk factors for heart failure in younger populations: A growing public health concern.年轻人群中心力衰竭的新兴风险因素:日益受到关注的公共卫生问题。
World J Cardiol. 2025 Apr 26;17(4):104717. doi: 10.4330/wjc.v17.i4.104717.
3
Global, regional, and national burden of heart failure and its underlying causes, 1990-2021: results from the global burden of disease study 2021.

本文引用的文献

1
Clinical Trial Design for Lipoprotein(a)-Lowering Therapies: JACC Focus Seminar 2/3.降低脂蛋白(a)疗法的临床试验设计:美国心脏病学会杂志聚焦研讨会2/3
J Am Coll Cardiol. 2023 Apr 25;81(16):1633-1645. doi: 10.1016/j.jacc.2023.02.033.
2
The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management.心脏瓣膜病的全球负担:从临床流行病学到管理
J Clin Med. 2023 Mar 10;12(6):2178. doi: 10.3390/jcm12062178.
3
Valvular Heart Disease Epidemiology.瓣膜性心脏病流行病学。
1990-2021年全球、区域和国家心力衰竭及其潜在病因的负担:全球疾病负担研究2021年结果
Biomark Res. 2025 Jan 23;13(1):16. doi: 10.1186/s40364-025-00728-8.
Med Sci (Basel). 2022 Jun 15;10(2):32. doi: 10.3390/medsci10020032.
4
Cigarette Smoking, Cessation, and Risk of Heart Failure With Preserved and Reduced Ejection Fraction.吸烟、戒烟与射血分数保留和降低的心力衰竭风险
J Am Coll Cardiol. 2022 Jun 14;79(23):2298-2305. doi: 10.1016/j.jacc.2022.03.377.
5
Recent Advances in the Rheumatic Fever and Rheumatic Heart Disease Continuum.风湿热和风湿性心脏病连续体的最新进展
Pathogens. 2022 Jan 28;11(2):179. doi: 10.3390/pathogens11020179.
6
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净治疗射血分数保留的心力衰竭。
N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27.
7
Global Differences in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.射血分数保留的心力衰竭的全球差异:PARAGON-HF 试验。
Circ Heart Fail. 2021 Apr;14(4):e007901. doi: 10.1161/CIRCHEARTFAILURE.120.007901. Epub 2021 Apr 19.
8
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.心力衰竭的通用定义和分类:美国心力衰竭学会、欧洲心脏病学会心力衰竭协会、日本心力衰竭学会和心力衰竭通用定义写作委员会的报告:得到加拿大心力衰竭学会、印度心力衰竭协会、澳大利亚和新西兰心脏病学会以及中国心力衰竭协会的认可。
Eur J Heart Fail. 2021 Mar;23(3):352-380. doi: 10.1002/ejhf.2115. Epub 2021 Mar 3.
9
Heart failure in the last year: progress and perspective.去年心力衰竭领域:进展与展望。
ESC Heart Fail. 2020 Dec;7(6):3505-3530. doi: 10.1002/ehf2.13124. Epub 2020 Dec 5.
10
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.恩格列净治疗心力衰竭的心血管和肾脏结局。
N Engl J Med. 2020 Oct 8;383(15):1413-1424. doi: 10.1056/NEJMoa2022190. Epub 2020 Aug 28.